Tvardi Therapeutics, Inc. (TVRD) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Tvardi Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -1.75x | -0.11x | -0.39x | -0.54x | -0.08x | 0.77x |
| P/B Ratio | 1.52x | -1.62x | -0.74x | -1.02x | 0.03x | 0.03x |
| P/S Ratio | 0.00x | 1.04x | 2.19x | 1.09x | 0.30x | 0.05x |
| Profitability | ||||||
| Gross Margin | 0.0% | 88.6% | 69.3% | 82.1% | 93.3% | 0.0% |
| Operating Margin | 0.0% | -781.6% | -579.4% | -209.1% | -386.8% | 4.0% |
| Net Margin | 0.0% | -993.0% | -565.2% | -204.2% | -384.1% | 6.2% |
| EBITDA Margin | 0.0% | -877.1% | -561.1% | -200.2% | -377.3% | 6.5% |
| Liquidity | ||||||
| Current Ratio | 2.86x | 11.03x | 7.97x | 10.31x | 9.84x | 10.55x |
| Quick Ratio | 2.86x | 10.81x | 7.97x | 10.31x | 9.69x | 10.55x |
| Leverage | ||||||
| Debt/Equity | 0.01x | -9.68x | -0.01x | -0.05x | 0.02x | 0.02x |
YoY = year-over-year change. Source: FMP..